26 results
F-1/A
EX-1.1
IMCR
Immunocore Holdings plc
1 Feb 21
Registration statement (foreign) (amended)
6:21am
on Schedule II(c) hereto, taken together (collectively, the “Pricing Disclosure Package”), as of the Applicable Time, did not, and as of each Time … by and taken together with the Pricing Disclosure Package, as of the Applicable Time, did not, and as of each Time of Delivery will not, include any untrue
F-1/A
EX-1.1
IMCR
Immunocore Holdings plc
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
, as supplemented by the information listed on Schedule II(c) hereto, taken together (collectively, the “Pricing Disclosure Package”), as of the Applicable Time, did … Communication, as supplemented by and taken together with the Pricing Disclosure Package, as of the Applicable Time, did not, and as of each Time of Delivery
F-1
EX-10.9
IMCR
Immunocore Holdings plc
15 Jan 21
Registration statement (foreign)
4:57pm
” means [***].
1.53 “Full Data Package” means, with respect to each Other HLA/MAGE-A4 Compound: (a) any relevant information within Immunocore’s Control … in such Full Data Package shall be mutually agreed to by the Parties.
1.54 “Global Development Budget” is defined in 5.7.1.
1.55 “Global Development
DRS/A
EX-10.8
IMCR
Immunocore Holdings plc
22 Dec 20
Draft registration statement (amended)
12:00am
” means [***].
1.53 “Full Data Package” means, with respect to each Other HLA/MAGE-A4 Compound: (a) any relevant information within Immunocore’s Control … in such Full Data Package shall be mutually agreed to by the Parties.
1.54 “Global Development Budget” is defined in 5.7.1.
1.55 “Global Development
DRS/A
EX-10.7
IMCR
Immunocore Holdings plc
22 Dec 20
Draft registration statement (amended)
12:00am
” means the Immunocore Foreground IP.
1.33 “Full Data Package” means with respect to each Compound: (a) any relevant information within Immunocore’s … Control related to existing or potential Patents related to such Compound(s).. The format and depth of data to be provided in such Full Data Package
F-1
EX-10.8
pow44zc
15 Jan 21
Registration statement (foreign)
4:57pm
DEF 14A
j4xzpfjsfmc5y9yqbck
12 Apr 24
Definitive proxy
4:20pm
PRE 14A
kh943cx9r h5v
2 Apr 24
Preliminary proxy
4:45pm
DRS/A
EX-10.4
f8ipv8tk
22 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
rjul8 vv8
22 Dec 20
Draft registration statement (amended)
12:00am
F-1
EX-10.5
cjtwdqk1w501arsb5ns
15 Jan 21
Registration statement (foreign)
4:57pm
F-1
EX-10.6
b1q0rp7z m1qdu84hg1
15 Jan 21
Registration statement (foreign)
4:57pm
DRS/A
EX-10.9
r5uw 8qb20
22 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.6
3y95 xyenpma60
22 Dec 20
Draft registration statement (amended)
12:00am
F-1
EX-10.10
5xce2nnngp3pb
15 Jan 21
Registration statement (foreign)
4:57pm
F-1
EX-10.7
odp1zh
15 Jan 21
Registration statement (foreign)
4:57pm
DRS/A
sgrmrr7z5
19 Nov 20
Draft registration statement (amended)
12:00am
20-F
0yoz63idse2gh2nbxv
25 Mar 21
Annual report (foreign)
7:01am
DRS
oa810xv apcm33
17 Nov 20
Draft registration statement
12:00am
F-1/A
w2ezv8eh
1 Feb 21
Registration statement (foreign) (amended)
6:21am